Insulin Analog class drugs

17 results
  • admelog

    (insulin lispro)
    Sanofi-Aventis U.S. LLC
    ADMELOG is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
  • apidra

    (insulin glulisine)
    sanofi-aventis U.S. LLC
    APIDRA is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
  • basaglar

    (Insulin glargine)
    Eli Lilly and Company
    BASAGLAR® is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus, and in adults with type 2 diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.
  • fiasp

    (insulin aspart injection)
    Novo Nordisk
    FIASP is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
  • humalog

    (Insulin lispro)
    Eli Lilly and Company
    HUMALOG is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
  • humalog

    (Insulin lispro)
    Eli Lilly and Company
    HUMALOG Mix75/25 is indicated for improving glycemic control in adults with diabetes mellitus. It has fixed proportions of rapid-acting and intermediate-acting insulins, limiting adjustments for basal and prandial doses.
  • humalog

    (Insulin lispro)
    Eli Lilly and Company
    HUMALOG Mix50/50 is indicated for improving glycemic control in adults with diabetes mellitus. However, it has limitations as the fixed proportions of rapid-acting and intermediate-acting insulins prevent adjustments for basal and prandial dosing.
  • lantus

    (insulin glargine)
    sanofi-aventis U.S. LLC
    LANTUS is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.
  • levemir

    (insulin detemir)
    Novo Nordisk
    LEVEMIR is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.
  • lyumjev

    (Insulin lispro-aabc)
    Eli Lilly and Company
    LYUMJEV® is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.